Clinical readout
Allergan Aesthetics reports facial satisfaction gains in GLP-1 users
Two open-label studies tested neurotoxin, filler and skincare treatment in adults taking GLP-1 drugs. In one, 30 participants reported a 42.4-point average rise in satisfaction with their facial appearance; an interim look at 25 patients in the other showed a 39.6-point gain at three months. Most treatment-related side effects were mild.
Written by Gosset from public sources. Source types: Press release. Sources are available to Gosset users. Log in to see them.